Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...

A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic.

How GLP-1 therapies could help build a healthier, more productive workforce—and what that would mean for how we live together ...

A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, manufactured by Novo Nordisk. Reuters Eli Lilly said Wednesday that its obesity drug Zepbound ...

Trump could keep Biden’s commitment to have Medicare pay for weight loss drugs such as Ozempic and Wegovy. But would ...

My weight concerns mainly injure my considerable vanity, and I’m not about to outsource my self-esteem issue to Big Pharma if ...

Ozempic is synonymous with weight ... after taking Wegovy for one year and four months, according to Novo Nordisk. Four years after starting semaglutide, patients maintained an average weight loss ...

Tirzepatide may be more effective than semaglutide in helping people lose weight. At least that's the findings from recent ...

The Biden administration proposed expanding coverage of weight loss medication to Medicaid and Medicare recipients. RFK Jr.

People who use Ozempic or Wegovy for weight loss often find ... Levy tells TODAY.com. One Ozempic patient previously told TODAY.com she could once eat a whole pizza, but after using the medication ...

Starting in the new year, the region’s largest health insurer will no longer cover popular diabetes drugs for the purposes of weight loss ... 1 agonists — commonly sold under brand names like ...

Have you heard the story of a breakthrough weight loss medicine called rimonabant ... Like rimonabant before it, wegovy (called a "GLP-1 agonist" due to its ability to simulate the effects ...